Extended extracorporeal photochemotherapy with extracorporeal administration of 8-methoxypsoralen in systemic sclerosis. An Austrian single-center study

Photodermatology Photoimmunology and Photomedicine

Volumn 16, Issue 5, 2000, Pages 216-223

  Muellegger, R R ^a   Hofer, A ^a   Salmhofer, W ^a   Soyer, H P ^a   Kerl, H ^a   Wolf, P ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Extracorporeal photochemotherapy; Parenteral 8 methoxypsoralen; Systemic sclerosis

Indexed keywords

METHOXSALEN;

ADULT; AGED; ARTICLE; AUSTRALIA; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; IMMUNOMODULATION; PHOTOCHEMOTHERAPY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; QUALITY OF LIFE; SAFETY; SCORING SYSTEM; SIDE EFFECT; SKIN MANIFESTATION; SYSTEMIC SCLEROSIS; TREATMENT OUTCOME;

ADULT; AGED; AUSTRIA; COMBINED MODALITY THERAPY; FEMALE; HUMAN; METHOXSALEN; MIDDLE AGE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; QUALITY OF LIFE; SCLERODERMA, SYSTEMIC; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 0033813629     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0781.2000.160505.x     Document Type: Article

References (38)

1. Scleroderma
2. Systemic sclerosis
3. Treatment of cutaneous T cell lymphoma by extracorporeal photochemotherapy: Preliminary results
4. Photopheresis for the treatment of cutaneous T cell lymphoma
5. Treatment of erythrodermic cutaneous T cell lymphoma with extracorporeal photochemotherapy
6. Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes
7. Regulation of autoimmune disease: Physiological and therapeutic
8. Specific vaccination against photoinactivated cloned T cells
9. Extracorporeal photochemotherapy induces the production of tumor necrosis factoralpha by monocytes: Implications for the treatment of cutaneous T cell lymphoma and systemic sclerosis
10. Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris
11. Pemphigus vulgaris treated with photopheresis
12. Unresponsive severe generalized pemphigus vulgaris successfully controlled by extracorporeal photopheresis
13. Treatment of rheumatoid arthritis by extracorporeal photochemotherapy: A pilot study
14. Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus: A pilot study
15. Extracorporeal photochemotherapy as adjunctive treatment in juvenile dermatomyositis: A case report
16. Treatment of autoimmune disease with extracorporeal photochemotherapy: Progressive systemic sclerosis
17. Treatment of systemic sclerosis with extracorporeal photochemotherapy: Results of a multicenter trial
18. Photopheresis in systemic sclerosis: Clinical and serological studies using markers of collagen metabolism
19. Extracorporeal photochemotherapy in progressive systemic sclerosis
20. Extracorporeal photochemotherapy in systemic sclerosis and severe morphea
21. Three cases of progressive systemic sclerosis treated with extracorporeal photochemotherapy
22. Management of severe scleroderma with long-term extracorporeal photopheresis
23. Progressive systemische sklerodermie. Behandlungsergebnisse unter extrakorporaler photopherese
24. Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis)
25. Extracorporeal photochemotherapy in progressive systemic sclerosis: A follow-up study
26. Parenteral administration of 8-methoxypsoralen in photopheresis
27. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
28. Reliability of skin involvement measures in scleroderma
29. Dosage guidelines: Extracorporeal photochemotherapy (photopheresis)
30. FDA Arthritis Advisory Committee meeting: Analgesics guidelines; Topical NSAIDs; Extracorporeal photochemotherapy in scleroderma
31. Photochemotherapy in systemic sclerosis: The stage is set
32. Price of technology, a blind spot
33. Photopheresis for scleroderma? No!
34. Photopheresis for scleroderma? Let's abandon the innuendos and get to the data
35. The natural history of skin involvement in progressive systemic sclerosis
36. Why everything (or nothing) seems to work in the treatment of scleroderma
37. Ultrasound examination of skin thickness in patients with progressive systemic sclerosis (scleroderma)
38. Outcome measurements in scleroderma clinical trials